A $114-million Scottish Center for Regenerative Medicine (SCRM) will be developed by the University of Edinburgh in collaboration with Scottish Enterprise. The SCRM will provide research facilities, manufacturing capacity, and commercialization facilities.
The Scottish Executive will provide support for the SCRM with more than $46M in funding. “This backing will allow Scotland to build on its international lead,” says University of Edinburgh principal, Timothy O'Shea.
The SCRM, which will be part of the new Center for Biomedical Research at Edinburgh’s Little France, will be unique in Europe and is thought to be equaled only by Kobe in Japan. It will have three main elements: high-quality accommodation to support 220 academic researchers, a center for scale-up development and manufacturing of cells, and multi-occupancy space to house commercial regenerative medicine research organizations and spin-outs.